|
Transaction Information
On February 9, 2021, Assertio Holdings, Inc. (NASDAQ: ASRT), a commercial-stage pharmaceutical company, has closed sales of 22,600,000 shares of its common stock to certain institutional investors in a registered direct offering. The shares were sold at the purchase price of $0.62 per share, resulting in the gross proceeds to Assertio Holdings, Inc. of approximately $14 million.
On February 12th, 2021, Assertio Holdings, Inc. has closed sales of 35,000,000 shares of its common stock to certain institutional investors in a registered direct offering. The shares were sold at the purchase price of $0.98 per share, representing a premium to market based on applicable Nasdaq "minimum price" rules. The gross proceeds to Assertio Holdings, Inc. from the registered direct offering were approximately $34.3 million.
Assertio Holdings, Inc. intends to use the net proceeds from both offerings for general corporate purposes, including general working capital.
Roth Capital Partners acted as sole placement agent for both of the registered direct offerings.
About Assertio Holdings, Inc.
Assertio is a leading commercial pharmaceutical company bringing differentiated products to patients. The Company has a robust portfolio of branded prescription products in three areas: neurology, hospital and pain and inflammation. Assertio has grown through business development including licensing, mergers and acquisitions. For more information, please visit
www.assertiotx.com.
(Source: Company Press Release | 02.12.21)
About Roth Capital Partners
Roth Capital Partners, LLC (ROTH), is a relationship-driven investment bank focused on serving emerging growth companies and
their investors. As a full-service investment bank, ROTH provides capital raising, M&A advisory, analytical research, trading,
market-making services and corporate access. Headquartered in Newport Beach, CA, ROTH is privately-held and employee owned, and
maintains offices throughout the U.S. For more information on ROTH, please visit
www.roth.com. |
|
Date of Announcement:
03.15.21
The material, information and facts discussed in this announcement other than the information regarding Roth Capital Partners, LLC
("ROTH") and its affiliates, are from sources believed to be reliable, but are in no way guaranteed to be complete or accurate. This announcement should not be used as a complete analysis of any
companies, securities or topics discussed herein. Additional information is available upon request. This is not, however, an offer or solicitation of the securities discussed. Any opinions or
estimates in this announcement are subject to change without notice. An investment in any security based on this announcement may involve risks and uncertainties that could cause actual results to differ
materially from the forward-looking statements. Additionally, such investments may involve a high degree of risk and may not be suitable for all investors. No part of this announcement may be
reproduced in any form without the express written permission of Roth. Copyright 2021. |
